Phone us
+65 6602 3826/+65 92338835
Biorisk encompasses biosafety and biosecurity, where the hazards are biological agents and its toxins. DNV has worked with many world leading agencies involved in research, diagnosis and management of infectious diseases. We have a team of experts with experience in operation of scientific environments, and have developed a practical and effective approach in managing biorisk.
Biorisk services
DNV has worked with many world leading agencies involved in research, diagnosis and management of infectious diseases. We have a team of experts with extensive scientific experience, and have developed a practical and effective approach in addressing and managing the various aspects of biorisk.
Our expertise applies to biorisk management principles and strategies for sectors working with potentially harmful biological organisms. We also have services relating to pandemic preparedness and business continuity planning.
Our risk based approach of managing biorisk is able to help your organisation manage these risks effectively in and outside of the laboratory.
BSL3 facility certification
A process whereby a laboratory is independently assessed and certified against criteria derived from the World Health Organisation Biosafety Manual. The approach reflects internationally recognised certification principles.
Biorisk HAZOP
HAZOP is a well known hazard identification technique that ensures comprehensive and systematic coverage of all the relevant areas in the initial design or change of a facility. During a HAZOP the review team searches the design, looking for process deviations and assessing their impact.
Biorisk Assessment: SIL Studies
DNV has developed a systematic approach to evaluate the safety integrity levels (SIL) required for safety related systems containment facilities, equipment and associated processes. The methodology can be applied at any stage of the design lifecycle and provides a practical way of demonstrating risk acceptability, including compliance with legislative requirements.
Biorisk AR&M
AR&M (availability, reliability & maintainability) studies are used to compare alternative designs, maintenance approaches and operating strategies. A detailed understanding of the facility systems or processes is obtained by evaluating the main contributors to failure scenarios.
Facility risk assessment
Facility risk assessments have an enormous potential to improve the safety of a laboratory facility by recognising and eliminating potential problems at the design stage. A number of recognised approaches can be used and this includes SWIFT, HAZOP, AR&M and SIL studies.
Infection control risk assessment, audit and training
A new strain of influenza virus is spreading around the world causing public health concerns, costly disruption to business and anxiety to individuals and their families. In such a situation, understanding the prevention and control of infection is essential for the well-being and safety of the staff, family and community.
Laboratory commissioning & validation
Commissioning and validation provides assurance that all relevant measures in the specification have been incorporated into the finished facility.
Training
DNV has designed a series of training courses to provide laboratory managers, biosafety personnel and scientific staff with the required skills and aptitudes necessary to effectively manage biorisk.
Laboratory task risk assessment
Accidents can occur when carrying out simple, daily tasks within the laboratory. Workers can face many hazards on a daily basis from chemicals, radioactivity, physical hazards (eg, trips hazards, heavy objects), electricity, and of course biological agents themselves. Task risk assessment is an essential part of biosafety management in the laboratory.
Contact us
Related links
Hot topics
Biorisk – a global issue
The management of biosafety and biosecurity (collectively know as biorisk) have become a vital global issue, especially in light of the laboratory-acquired cases of SARS in Singapore, Taiwan and China in 2004.
Combating avian flu
Indonesia is now the country with the highest number of human fatalities caused by the H5N1 influenza virus, often referred to as ‘avian flu’. In an effort to tackle the deadly disease, the prestigious Eijkman Institute in Jakarta has built a new biosafety level 3 (BSL3) laboratory – with the help of DNV.
A Star in the making
The Agency for Science, Technology and Research (A*STAR) is leading the way in biomedical research – with the help of DNV.